Weekly versus triweekly cisplatin-based concurrent chemoradiotherapy in the treatment of locally advanced cervical carcinoma: An updated meta-analysis based on randomized controlled trials

BACKGROUND: Radiotherapy concurrent with cisplatin is the standard regimen used for treatment of locally advanced cervical carcinoma. In this meta-analysis, survival, recurrence, compliance, and acute adverse effects were compared between weekly and triweekly cisplatin-based concurrent chemoradiothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Jiahao, Zhang, Zheng, Bian, Dongyan, Chen, Qingqing, Hu, Qunchao, Ji, Shengjun, Gu, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946561/
https://www.ncbi.nlm.nih.gov/pubmed/31895831
http://dx.doi.org/10.1097/MD.0000000000018663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946561/
https://www.ncbi.nlm.nih.gov/pubmed/31895831
http://dx.doi.org/10.1097/MD.0000000000018663

Ejemplares similares